ImmunoPrecise Antibodies Ltd. (IPA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 20.18M |
| Enterprise Value | 22.91M |
| P/E Ratio | -7.42 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 5.41 |
| Price/Book Ratio | 6.6 |
| Enterprise/Revenue | 4.83 |
| Enterprise/EBITDA | -8.14 |
| Fiscal Year | April 30, 2025 |
| Most Recent Quarter | January 31, 2026 |
| Profit Margin | -0.66 |
| Operating Margin | -0.65 |
| Return On Assets | -0.53 |
| Return On Equity | -0.63 |
| Revenue | 24.52M |
| Revenue/Share | 0.39 |
| Gross Profit | 13.55M |
| EBITDA | -28.86M |
| Net Income | -30.23M |
| Diluted EPS | -0.91 |
| Total Cash | 14.18M |
| Total Cash/Share | 0.3 |
| Total Debt | 3.55M |
| Total Debt/Equity | 0.24 |
| Current Ratio | 3.74 |
| Book Value Per Share | 0.32 |
| 52-Week Change | 297.06 |
| 52-Week High | 3.25 |
| 52-Week Low | 0.27 |
| Moving Average 50 Days | 1.94 |
| Moving Average 200 Days | 0.84 |
| Average Volume | 2.91M |
| Shares Outstanding | 46.15M |
| % Held by Institutions | 0.02 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | November 23, 2020 |